CLINICAL TRIALS PROFILE FOR SOTYKTU
✉ Email this page to a colleague
All Clinical Trials for SOTYKTU
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT05821374 ↗ | Deucravacitinib in PG | Not yet recruiting | Bristol-Myers Squibb | Early Phase 1 | 2023-06-01 | The main goal of this study is to see if the study drug called "Deucravacitinib" is safe and effective in treating people with pyoderma gangrenosum (PG). |
NCT05821374 ↗ | Deucravacitinib in PG | Not yet recruiting | Dartmouth-Hitchcock Medical Center | Early Phase 1 | 2023-06-01 | The main goal of this study is to see if the study drug called "Deucravacitinib" is safe and effective in treating people with pyoderma gangrenosum (PG). |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for SOTYKTU
Condition Name
Clinical Trial Locations for SOTYKTU
Trials by Country
Clinical Trial Progress for SOTYKTU
Clinical Trial Phase
Clinical Trial Sponsors for SOTYKTU
Sponsor Name